Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Pulmonology
•
Diffuse Parenchymal Lung Disease
How frequently do you monitor CT scans, PFTs, and TTEs in patients with ILA or mild ILD?
Related Questions
Would you offer lung SBRT in a patient with Pulmonary Langerhans Cell Histiocytosis (PLCH)?
What is your approach to managing ILD associated with inflammatory bowel disease?
What factors would encourage you to choose abatacept vs tocilizumab in a patient with RA-ILD with a UIP pattern of pulmonary fibrosis?
How often do you monitor pulmonary function tests in patients with fibrotic lung disease?
Is it still significant to denote the etiology of ILD in a patient with PPF?
Is it necessary to prescribe a steroid taper after two weeks of high-dose prednisone (60 mg daily)?
What criteria do you use to determine when to start a steroid-sparing agent for hypersensitivity pneumonitis?
Would you consider adding or switching to pirfenidone for a patient with progressing UIP (based on imaging and PFTs) who is currently on nintedanib?
What factors do you consider when determining whether to perform a biopsy for the diagnosis of organizing pneumonia?
What immunosuppression regimens do clinicians use in patients with progressive RB-ILD despite smoking cessation and prednisone?
